A new Cannabis Use Disorder Heart Attack Study suggests increased cardiovascular risk in hospitalized MASH cirrhosis patients—but what was actually measured may surprise you. This physician-led analysis separates diagnosis codes from pharmacology and headlines from nuance. Before we panic—or dismiss—we should read carefully, think clearly, and protect hearts with precision rather than fear.